Xconomy: Lewis Cantley News, Articles and Opinions

“lewis-cantley” Archives

Entry	Author	Date	Location
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech	Ben Fidler	12/30/16	New York
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors	Ben Fidler	03/30/16	New York
Hear Lew Cantley, Others on Shaping NY Biotech on March 29	Ben Fidler	03/11/16	New York
New York City: En Route to a Bio Cluster	Louis Levy and Vicki Sato	02/29/16	New York
Alexandria, Lodo Founders to Join NY’s Bio Disruptors on March 29	Thea Bissell	02/23/16	New York
Early Bird Special Ends Today for New York’s Life Science Disruptors	Thea Bissell	02/02/16	New York
NYC’s Disruptive Biotech Startups take the Stage on March 29	Ben Fidler	01/21/16	New York
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More	Ben Fidler	01/08/16	Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet	Ben Fidler	01/06/16	New York
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech	Ben Fidler	10/16/13	Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut	Ben Fidler	07/24/13	Boston
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More	Bernadette Tansey	02/22/13	New York
Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars	Luke Timmerman	02/20/13	National
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage	Arlene Weintraub	10/11/11	Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer	Ryan McBride	08/19/10	Boston
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells	Luke Timmerman	11/24/08	Boston
Page 1 of 1